pharma report

56

Upload: ana-orchid-vitor-busa

Post on 02-Nov-2014

770 views

Category:

Health & Medicine


6 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Pharma report
Page 2: Pharma report
Page 3: Pharma report

is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia.

Page 4: Pharma report

Depression- is a common mental disorder that presents with depressed mood, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy, and poor concentration. 

Three (3) types of depression: Reactive depression - usually has sudden onset

after a precipitating event › The client knows why she or he is depressed and may

call this the “blues.”› Usually last for a month and benzodiazepine agent

may be required

Page 5: Pharma report

Major depression- is characterized by loss of interest in work and home, inability to complete task, and deep depression (dysphoria)

Bo-polar affective disorder – involves swings between two moods, the manic (euphoric) and the depressive (dysphoria).

Electroconvulsive Therapy- was used to treat psychosis and depression before the introduction of antipsychotics and antidepressants.

Page 6: Pharma report

St.John’s wort – can decrease reuptake of the neurotransmitters serotonin, norepinephrie, and dopamine.

Gingko biloba- can be used for memory enhancement and dementia

Page 7: Pharma report

Gingko biloba

St. John’s wort

Page 8: Pharma report

Four groups (4): tricyclic antidepressants (TCAs) selective serotonin reuptake

inhibitors (SSRIs) atypical antidpressants that

affect various neurotransmitters monoamine oxidase inhibitors

(MAOIs)

Page 9: Pharma report
Page 10: Pharma report

are used to treat major depression, because they are effective and less expensive than SSRIs and other drugs.

Imipramine was the first TCA marketed in the 1950s.

The action is to block the uptake of the neurotransmitters norepinephrine and serotonin in the brain.

Page 11: Pharma report

This group of drugs elevates mood , increased interest in daily living and activity and decreases insomia.

Given at night to minimize problems caused by their sedative action.

When discontinuing TCAs, the drugs should be gradually decreased to avoid withdrawal syndrome such as nausea, vomiting, anxiety, and akathisia.

Page 12: Pharma report

Examples are: Amitriptyline (Elavil) doxepin (Sinequan) trimipramine (Surmontil) imipramine desipramine nortriptyline

Polydrug therapy- the practice of giving several antidepressant or antipsychotic together, should be avoided because of possible serious side effects.

Page 13: Pharma report

orthostatic hypotension sedation anticholigernic effects cardiac toxicity such as dysrhythmias seizures allergic reaction (skin rash , pruritus,

and petechiae) sexual dysfunction (impotence and

amennorhea) blood dyscrasias (leukopenia,

thrombocytopenia, and agranulocytosis)

 

Page 14: Pharma report

ContraindicationsAll antidepressants are contraindicated in patients with a history of hypersensitivity to any component.

Page 15: Pharma report

Alcohol,hynotics, sedatives and barbiturates potntieate central nervours system (CNS ) depression when taken with TCAs.

Concurrent use of MAOIs with amitrityline may lead to cardiovascular instability and toxic psychosis.

Anti-thyroid medications taken with amitripyline may increase the risk of dysrhymias

Page 16: Pharma report
Page 17: Pharma report

was first classified as second generation and anti depressants.

Today they have been reclassified asselective serotonin reuptake inhibitors ( SSRIs ).

blocks the reuptake of serotonin into the nerve terminal of the CNS, thereby enhancing its transmission at the serotonergic synapse.

do not block the uptake of dopamine or nor-epinephrine, nor they block the cholinergic alpha- adrenergic receptors.

Page 18: Pharma report

The primary use of SSRIs is for major depressive disorder.

They are also effective fro treating anxiety disorders such as obsessive-compulsiveness, panmic, phobias,post traumatic stress disorders, and other forms of anxiety

EXAMPLE OF SSRIs Fluoxetine ( Prozac ) Fluvoxamine ( Luvox ) Sertraline ( Zoloft ) Paroxetine ( Paxil ) Citalopram ( Celexa ) Escitalopram ( Lexapro )

Page 19: Pharma report

Dry mouth Blurred vision Insomnia Headache Nervousness Anorexia Nausea Diarrhea Suicidal ideation Some clients may experience sexual dysfunction

Page 20: Pharma report
Page 21: Pharma report

also called second-generation antidepressants became available in the 1980s and have been

used for major depression, reactive depression and anxiety

They affect 1 or 2 of the 3 neurotransmitters: › Serotonin› Norepinephrine› Dopamine

should not be taken with MAOIs and should not be used within 14 days after discontinuing MAOIs.

Page 22: Pharma report

Examples: amoxapine (Asendin) bupropion (Wellbrutin) maprotiline (Ludiomel) nefazodone (Serzone) trazodone (Desyrel) mirtazipine (Remeron) venlafaxine (Effexor)

Page 23: Pharma report

Manic episodes in persons with bipolar disorder (If not combined with a mood-stabilizing drug, atypical antidepressants may induce manic episodes in individuals with bipolar disorder.)

Seizures (Atypical antidepressants may lower the threshold for seizures; that is, seizures may occur more easily. Caution is advised for individuals prone to seizures or those who have a history of seizures.)

Drowsiness (Caution is advised when operating machinery, driving, or performing other tasks that require alertness.)

Page 24: Pharma report
Page 25: Pharma report

relieve depression by preventing the enzyme monoamine oxidase from metabolizing the neurotransmitters norepinephrine, serotoninand dopamine in the brain

are currently not the antidepressants of choice and are usually prescribed when the client does not repond to TCAs or second-generation antidepressants.

Should not be taken together with TCA when treating depression

Page 26: Pharma report

MAO- A – inactivates dopamine in the brain

MAO- B – inactivates norepinephrine and serotonin

Page 27: Pharma report

1. tranyclypromine sulfate (Panate)

2. isocarboxazid (Marplan)3. phenelzine sulfate (Nardil)

Page 28: Pharma report

Orthostatic hypotension CNS stimulation (agitation,

restlessness, insomnia) Anticholinergic effects

Page 29: Pharma report

MAO inhibitors may cause serious and possibly life-threatening reactions, such as sudden high blood pressure, when taken with certain foods, beverages, or medicines.

The dangerous reactions may not begin until several hours after consuming these items.

Aged cheeses, red wines, smoked or pickled meats, chocolate, caffeinated beverages, and foods containing monosodium glutamate (MSG) are among the foods and drinks to be avoided

Page 30: Pharma report

Anyone who is taking MAO inhibitors should not use any other medicine unless it has been approved or prescribed by a physician who knows that they are taking MAO inhibitors, this includes:› nonprescription (over-the-counter)

medicines such as sleep aids; medicines for colds, cough,hay

fever, or asthma (including nose drops or sprays); medicines to increase alertness or keep from falling asleep; and appetite control products.

Page 31: Pharma report
Page 32: Pharma report

also known as neuroleptics or psychotropics

have been available since the mid-1950s.

refers to any drug that modifies psychotic behavior and exerts an antipsychotic effect

Page 33: Pharma report

Psychosis or losing contact with reality is manifested in a variety of mental or psychiatric disorders is usually characterized by more than one symptom, but

these may include difficulty in processing information and coming to a conclusion, delusions, hallucinations, incoherence, catatonia, and aggressive or violent behavior

sometimes called dopamine antagonist block D2 dopamine receptors in the brain, reducing

psychotic symptoms many antipsychotics block the chemoreceptor trigger zone

and vomiting center in the brain, producing an antiemetic effect

Page 34: Pharma report

Schizophrenia a chronic psychotic disorder is the major category of psychosis in

which many of these symptoms are manifested

symptoms usually develop in adolescence or early adulthood

Page 35: Pharma report

“Positive” symptoms - may be characterized exaggeration of

normal function, incoherent speech, hallucination, delusion, and paranoia

“Negative” symptoms – are characterized by a decrease or loss in

function and motivation- there is poverty of speech content, poor

self-care, and social withdrawal- tend to be more chronic and persistent

Page 36: Pharma report

Are divided into 2:› Typical Antipsychotics

Division of typical antipsychotics Phenotiazines Nonphenotiazine

> Atypical Anti Psychotics -

Page 37: Pharma report

Antipsychotics block the action of dopamine and thus may be classified as dopaminergic antagonists. There are five subtypes of dopaminergic antagonists.

There are five subtypes of dopamine receptors. D1 through D2. All antipsychjotics block the D1 (dopaminergic) receptor, which in turn promotes the presence of EPS, resulting in pseudoparkinsonism. Atypical antipsychotics have a weak affinity to D2 receptors, a stronger affinity to D4 receptors and they block the serotonin receptor.

Page 38: Pharma report

Extrapyramidal Syndrome

Pseudoparkinsonism, which resembles symptoms of Parkinson’s disease is a major side effect of typical antipsychotic drugs.

Symptoms: stooped posture masklike facies rigidity tremors at rest, shuffling gait, pill-rolling motion of the hand, a and bradykinesia.

Page 39: Pharma report

Contraindications to Antipsychotic TreatmentNarrow angle glaucoma is an absolute contraindication to the use of antipsychotics. Antipsychotic treatment while a patient is suffering from glaucoma is inadvisable. Glaucoma must be treated before a patient can continue with an antipsychotic treatment.

Prostatic hypertrophy is a relative contraindication to the use of antipsychotics. Bethanechol at 25 to 50 mg/day can be used throughout treatment to offset the obstruction, but patients must be carefully monitored.

Page 40: Pharma report

Acute dystonia Symptoms usually occur in 5% of clients within

days of taking typical antipdsychotics This condition is treated with

anticholinergic/antiparkinsonism drugs such as benztropine (Cogentin).

The benzodiazepine lorazepam (Atrivan) may also be prescribe.

Characteristics of the reaction include:› muscle spasms of face, tongue, neack, and back; › facial grimacing; › abnormal or involuntary upward eye-movement; › and laryngeal spasms that can impair respiration

Page 41: Pharma report

Akathisia Incidence occurs in approximately 20% of

clients who take a typical psychotic drug. is best treated with a benzodiazepine 9e.g

lorazepam) or beta-blocker (e.g propranolol)

Characteristics:› trouble standing still, › is restless, › paces the floor, › and is in constant motion

Page 42: Pharma report

Tardive dyskinesia is a later phase of extrapyramidal reaction to

antipsychotics is a serious adverse rection occulting in clients who

have taken a antipsychotic drug for more than a year The likelihood of developing tardive dyskinesia

depends on the dose and duration of the antipsychotic factorCharacteristics:› protrusion and rolling of the tongue, › sucking and smacking movements of the lips in

chewing motion, › and involuntary movement of the body and

extremities.

Page 43: Pharma report

Neuroleptic Malignant Syndrome is a rare but potentially fatal condition associated with

antipsychotic drugs. Treatment of NMS involves immediate withdrawal of

antipsychotics, adequate hydration, benzodiazepines, and muscle relaxants such as dantolene (Dantrium).

Symptoms: involve muscle rigidity, sudden high fever, altered mental status, blood pressure fluctuations, tachycardia, dysrhythmias, seizures, rhabdomyolysis, acute renal failure, respiratory failure, and coma

Page 44: Pharma report
Page 45: Pharma report

In 1952 chlorpromazine hydrochloride (Thorazine) was the first phenothiazine introduced for treating psychotic behavior in clients in psychiatric hospitals

are subdivided into three groups:› aliphatic, › piperazine, › and piperidine

Page 46: Pharma report

produce a strong sedative effect, decreased blood pressure, and may cause moderate effect of EPS (pseudoparkinsonism).

Chlorpromazine (Thorazine) is in the aliphatic group and may produce pronounced orthostatic hypotension ( low blood pressure that occurs when an individual assumes an upright position from a supine position).

Page 47: Pharma report

produce a low sedative and strong antiemetic effect but have little effect on blood pressure.

They cause more EPS than other phenothiazines. examples of piperazine phenothiazines are fluphenazine (Prolixin) and perphenazine (Trilafon).

Page 48: Pharma report

have a strong sedative effect, cause few EPS, have a low to moderate effect on blood pressure , and have no antiemetic effect

Thioridazine ( MEllril ) is an example of piperidine phenothiazines.

Page 49: Pharma report
Page 50: Pharma report

Includes› Butyrophenone› Dibenzoxazepines› Dihydroindolone› Thioxanthene

Page 51: Pharma report

Drowsiness Dry mouth Increased heart rate Urinary retention Constipation Decrease blood pressure

Page 52: Pharma report

Dosage adjustment of an anticonvulsant may be necessary

If either aliphatic phenotiazine or the thioxanthene group is administered, a higher dose of anticonvulsant may be necessary

Antipsychotics interact with alcohol, hypnotics, sedatives, narcotics and benzodiazepines to potentiate the sedative effects of antipsychotics

Antipsychotics should not be given with other antipsychotic or antidepressant drugs except to control psychotic behavior for selected individuals who are refractory to drug therapy.

When discontinuing antipsychotics, the drug dosage should be reduced gradually

Page 53: Pharma report

Older adults usually require smaller doses of antipsychotics – from 25% to 50% less than young middle-aged adults

Dosage amount need to be individualized according to the client’s age and physical status

Page 54: Pharma report
Page 55: Pharma report

A new category of antipsychotics that was marketed in the US in the early 1990s

Differs from the typical/ traditional antipsychotics

 2 advantages of the atypical agents They are effective in treating negative

symptoms They are not likely to cause EPS or tardive

dyskinesia

Page 56: Pharma report

Atypical drugs available clozapine (Clozaril) risperidone (Risperdal) olanzapine (Zyprexa) quetiapine (Seroquel) paliperidone (Invega)